Instil Bio, Inc.
TIL
$16.00
$0.5453.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.97% | 65.86% | 20.07% | 57.42% | 76.00% |
| Total Depreciation and Amortization | -28.47% | -5.46% | -1.61% | -44.09% | -50.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,158.73% | -77.74% | 24.66% | -70.97% | -102.16% |
| Change in Net Operating Assets | -287.63% | -858.37% | 80.99% | 147.72% | 81.26% |
| Cash from Operations | 21.09% | -39.56% | 45.75% | 58.48% | 63.81% |
| Capital Expenditure | -- | -- | -- | -- | 99.55% |
| Sale of Property, Plant, and Equipment | -79.45% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.84% | 164.93% | -34.28% | -59.80% | -72.82% |
| Cash from Investing | -6.81% | 754.42% | 15.35% | -36.38% | -57.47% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 127.09% | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -242.11% | 149.41% | 89.04% | -162.50% | -127.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 622.18% | 99.08% | 125.43% | 66.78% | -73.78% |